By Drug Target Review2025-09-22T09:01:03
Scientists at the University of Liverpool have discovered Novltex, a new class of antibiotics that shows potent activity against deadly multidrug-resistant bacteria such as MRSA.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-01-04T16:08:55
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud